YCYongyu Chen

Yongyu Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yongyu Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systemic inflammatory biomarkers and their partial role in the association between diabetes and sarcopenia: A population-based study using NHANES data

    by Jingqian Qin, Xue Qiu, Bin Liang, Yongyu Chen, Tao Jiang

    The mediating role of inflammatory biomarkers in the association between diabetes and sarcopenia remains poorly quantified in general populations. This study aims to investigate this relationship and quantify the mediating effects of systemic inflammatory indicators. This cross-sectional study included 11,190 adults from the National Health and Nutrition Examination Survey 2011 to 2018. Weighted logistic regression and subgroup analyses were used to assess the association between diabetes and sarcopenia, defined by the Foundation for the National Institutes of Health criteria (appendicular skeletal muscle mass/body mass index). Mediation analysis with bootstrapping was performed to evaluate the mediating roles of white blood cells, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, and Systemic Immune-Inflammation Index. Diabetes was significantly associated with an increased risk of sarcopenia (odds ratio = 1.48, 95% confidence interval: 1.03–2.13, P = .042) after full adjustment. Mediation analysis revealed that white blood cells, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, and Systemic Immune-Inflammation Index mediated 28.48%, 26.58%, 7.36%, 6.54%, and 10.17% of this association, respectively (all P < .05). Diabetes is positively associated with sarcopenia risk, partially mediated by systemic inflammation. Readily available inflammatory biomarkers may aid in identifying high-risk diabetic patients for sarcopenia prevention.

  • Open Access

    Association of four insulin resistance surrogates with anemia among middle-aged and elderly individuals: a cross-sectional study from the China Health and Retirement Longitudinal Study

    by Yongyu Chen, Jiehua Deng, Zhongming Zhang, Peng Su

    Anemia is a prevalent global public health challenge. The aim of this study was to investigate the cross-sectional association between insulin resistance (IR) surrogates (TyG index, TG/HDL-C ratio, METS-IR, and eGDR) and anemia in middle-aged and elderly Chinese individuals. Data from the China Health and Retirement Longitudinal Study (CHARLS) wave 3 (2015) were analyzed. A total of 10,402 participants aged 45 years or older were included. Multiple logistic regression models and restricted cubic spline (RCS) analyses were employed to examine the associations, applying sampling weights to ensure national representativeness. Collinearity diagnostics were performed to validate model stability. In this cross-sectional study, 3,590 (34.5%) participants had anemia. After adjusting for confounders (including age, gender, socioeconomic status, lifestyle, and comorbidities), the TyG index, TG/HDL-C ratio, and METS-IR were inversely associated with anemia odds. For each unit increase in TyG, TG/HDL-C, and METS-IR, the odds of anemia decreased by 44% (OR = 0.56, 95% CI = 0.52-0.61), 10% (OR = 0.90, 95% CI = 0.88-0.92), and 5% (OR = 0.95, 95% CI = 0.93-0.96), respectively. Conversely, elevated eGDR levels (indicating lower insulin resistance) were associated with higher odds of anemia (OR = 1.28, 95% CI = 1.22-1.35 per unit increment, adjusted model without mathematical coupling). Non-linear dose-response relationships were observed for all four surrogates. Significant interactions were found between IR surrogates and demographics (age, gender) and lifestyle factors (smoking, BMI). Higher levels of TyG, TG/HDL-C, and METS-IR are associated with lower prevalence of anemia, whereas higher eGDR is associated with higher anemia prevalence in middle-aged and elderly Chinese adults. These findings highlight complex metabolic-hematologic interactions, though the cross-sectional design precludes causal inference. Further longitudinal research is warranted to elucidate the underlying mechanisms.

  • Open Access

    Bioinformatic validation and machine learning based exploration of B cells-related gene signatures in the context of strategies for precision therapy to acute myeloid leukemia

    by Yongyu Chen, Xue Qiu, Jiehua Deng, Jianchao Ma, Jiansheng Huang, Yequan Lu, Ruilin He, Bin Liang

  • Single-cell and bulk RNA sequencing reveals specific Trem2 positive B cell subtype niche after myocardial infarction in mice

    by Xue Qiu, Qiang Wang, Yongyu Chen, Bin Liang, Jiansheng Huang, Yequan Lu, Jianchao Ma, Lang Li

    This study aims to characterize B cell subtypes in mice following myocardial infarction (MI) and identify potential therapeutic targets for adverse remodeling post-MI. The scRNA-seq (GSE163129) and bulk RNA sequencing data (GSE19322) of mice post-MI were obtained from the GEO database. Seurat, gene set enrichment analysis, SCENIC analysis, Monocle 2 and NichNet analysis were performed in scRNA-seq data. Only the changes of immune cell populations in the infarct areas at different points after MI and pre - MI (steady - state) condition were compared. Bulk RNA-seq data for myocardium of post-MI in mice was used for validation. Twelve cell types were identified on scRNA-seq data and B cells were divided into five subtypes including B_Trem2 and others. B_Trem2 exhibited regulatory B (Breg) cells characteristics, displaying expressions of the cardiac repair gene Trem2, the anti-inflammatory marker Il10, and the myocardial remodeling molecule Spp1. B_Trem2 activated anti-inflammatory pathways. Nfe2l2, Rxrb, Zfp672, Prdm1 and Hivep3 were activated in the B_Trem2 subtype occupying the terminal stage of B cell development. Apoe was a potential activator of Spp1 overexpression in B_Trem2. Receptors of Apoe, namely Lrp1, Sdc4, and Sdc3, exhibited elevated expression within B_Trem2 subtype. This study identified a specific B cell subtype (B_Trem2) with Breg characteristics that overexpressed Spp1 in post- MI mice. Apoe may promote Spp1 expression in B_Trem2, by binding Apoe to Lrp1, Sdc4 and Sdc3 receptors on B_Trem2. This provides a new therapeutic target for MI.


  • Open Access

    Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018

    by Bin Liang, Xue Qiu, Jiansheng Huang, Yequan Lu, Hairong Shen, Jianchao Ma, Yongyu Chen

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) index may be a potential indicator for MASLD and advanced liver fibrosis, given its relevance to inflammation and plasma lipids. In this study, the hs-CRP/HDL-C index was investigated in relation to prevalent MASLD and advanced liver fibrosis. The study analyzed secondary data from the National Health and Nutrition Examination Survey (NHANES) 2017–2018 database. The hs-CRP/HDL-C index was calculated by the quotient of hs-CRP and HDL-C. Multiple logistic regression models, Cochran-Armitage trend tests, smooth curve fitting, threshold effect analyses, and stratified analyses were used to evaluate whether the hs-CRP/HDL-C index associated with MASLD and advanced liver fibrosis. The study cohort comprised 3684 participants, of whom 1268 (34.42%) were diagnosed with MASLD and 156 (12.28%) with advanced liver fibrosis. Logistic analyses adjusted for covariates revealed positive associations of the hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, consistent across all subgroups. Smooth curve fitting and threshold effect analyses revealed nonlinear relationships of hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, with inflection points at 0.8 for MASLD and 1.2 for advanced liver fibrosis. Additionally, significant interactions were observed between MASLD and covariates such as gender, smoking status, chronic kidney disease (CKD), and cancer. Similarly, the hs-CRP/HDL-C index exhibited positive correlations with advanced liver fibrosis across diverse subgroups, with notable interactions related to cancer. MASLD and advanced liver fibrosis were associated with hs-CRP/HDL-C index, indicating its potential utility as a clinical marker for these conditions.